Beyond Antibiotics: Mesenchymal Stem Cells and Bacteriophages-New Approaches to Combat Bacterial Resistance in Wound Infections Publisher Pubmed



Teymouri S¹ ; Yousefi MH^{2, 3} ; Heidari S⁴ ; Farokhi S⁵ ; Afkhami H^{3, 6, 7} ; Kashfi M^{6, 8}
Source: Molecular Biology Reports Published:2025

Abstract

Wound management is a major global health problem. With the rising incidence of diabetic wounds, accidents, and other injuries, the demand for prompt wound treatment has become increasingly critical. Millions of people suffer from serious, large wounds resulting from major accidents, surgeries, and wars. These wounds require considerable time to heal and are susceptible to infection. Furthermore, chronic wounds, particularly in elderly and diabetic patients, often require frequent medical interventions to prevent complications. Consequently, wound management imposes a significant economic burden worldwide. The complications arising from wound infections can vary from localized issues to systemic effects. The most severe local complication of wound infection is the non-healing, which results from the disruption of the wound-healing process. This often leads to significant pain, discomfort, and psychological trauma for the patient. Systemic complications may include cellulitis, osteomyelitis, and septicemia. Mesenchymal stem cells are characterized by their high capacity for division, making them suitable candidates for the treatment of tissue damage. Additionally, they produce antimicrobial peptides and various cytokines, which enhance their antimicrobial activity. Evidence shows that phages are effective in treating wound-related infections, and phage therapy has proven to be highly effective for patients when administered correctly. The purpose of this article is to explore the use of bacteriophages and mesenchymal stem cells in wound healing and infection management. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.